BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 9,710.00
-140.00 (-1.42%)
At close: Jun 5, 2026
BIO-FD&C Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 18,853 | 19,179 | 16,066 | 15,592 | 15,855 | 11,972 |
Other Revenue | -0 | -0 | -0 | -0 | - | -0 |
| 18,853 | 19,179 | 16,066 | 15,592 | 15,855 | 11,972 | |
Revenue Growth (YoY) | 13.64% | 19.37% | 3.04% | -1.66% | 32.44% | 38.57% |
Cost of Revenue | 6,334 | 6,305 | 4,852 | 4,563 | 4,859 | 4,895 |
Gross Profit | 12,519 | 12,874 | 11,214 | 11,029 | 10,996 | 7,077 |
Selling, General & Admin | 4,682 | 4,515 | 4,369 | 4,283 | 4,556 | 2,883 |
Research & Development | 1,523 | 1,652 | 1,699 | 1,429 | 1,449 | 815.9 |
Amortization of Goodwill & Intangibles | 93.23 | 91.48 | 89.77 | 69.25 | 26.16 | 25.93 |
Other Operating Expenses | - | - | - | - | - | 48.93 |
Operating Expenses | 6,680 | 6,621 | 6,362 | 5,995 | 6,116 | 3,939 |
Operating Income | 5,839 | 6,253 | 4,853 | 5,034 | 4,881 | 3,138 |
Interest Expense | -27.74 | -38.94 | -63.47 | -127.82 | -108.93 | -62.29 |
Interest & Investment Income | 1,198 | 1,223 | 1,334 | 1,098 | 564.04 | 30.95 |
Currency Exchange Gain (Loss) | 65.18 | -39.48 | 238.13 | 2.09 | 130.71 | 133.49 |
Other Non Operating Income (Expenses) | -10.99 | 2.49 | -26.73 | -25.13 | -19.47 | 44.7 |
EBT Excluding Unusual Items | 7,063 | 7,400 | 6,334 | 5,981 | 5,447 | 3,284 |
Gain (Loss) on Sale of Investments | 531.31 | 531.31 | -1,106 | 1,170 | -3.63 | - |
Gain (Loss) on Sale of Assets | 18.18 | 18.18 | -0.19 | 0.43 | - | 8.88 |
Pretax Income | 7,613 | 7,950 | 5,228 | 7,152 | 5,443 | 3,293 |
Income Tax Expense | 1,415 | 1,284 | 726.69 | 1,567 | 1,108 | 385.7 |
Net Income | 6,198 | 6,666 | 4,501 | 5,585 | 4,335 | 2,908 |
Net Income to Common | 6,198 | 6,666 | 4,501 | 5,585 | 4,335 | 2,908 |
Net Income Growth | 22.72% | 48.11% | -19.41% | 28.83% | 49.10% | 18.13% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 7 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 7 |
Shares Change (YoY) | 0.07% | 0.12% | -0.03% | -3.23% | 19.10% | 0.39% |
EPS (Basic) | 726.54 | 781.60 | 528.00 | 655.00 | 492.00 | 394.00 |
EPS (Diluted) | 725.98 | 781.00 | 528.00 | 655.00 | 492.00 | 393.00 |
EPS Growth | 22.63% | 47.92% | -19.39% | 33.13% | 25.19% | 17.66% |
Free Cash Flow | 5,877 | 6,304 | 4,779 | 4,057 | 5,421 | -3,330 |
Free Cash Flow Per Share | 688.40 | 738.65 | 560.57 | 475.82 | 615.19 | -450.12 |
Gross Margin | 66.40% | 67.13% | 69.80% | 70.74% | 69.35% | 59.11% |
Operating Margin | 30.97% | 32.60% | 30.20% | 32.29% | 30.78% | 26.21% |
Profit Margin | 32.88% | 34.76% | 28.01% | 35.82% | 27.34% | 24.29% |
Free Cash Flow Margin | 31.17% | 32.87% | 29.74% | 26.02% | 34.19% | -27.82% |
EBITDA | 7,208 | 7,574 | 6,066 | 6,121 | 5,930 | 3,764 |
EBITDA Margin | 38.23% | 39.49% | 37.75% | 39.26% | 37.40% | 31.44% |
D&A For EBITDA | 1,369 | 1,321 | 1,213 | 1,087 | 1,049 | 626.04 |
EBIT | 5,839 | 6,253 | 4,853 | 5,034 | 4,881 | 3,138 |
EBIT Margin | 30.97% | 32.60% | 30.20% | 32.29% | 30.78% | 26.21% |
Effective Tax Rate | 18.58% | 16.14% | 13.90% | 21.91% | 20.36% | 11.71% |
Advertising Expenses | - | - | - | - | - | 11.56 |